| アブストラクト | BACKGROUND: Non-steroidal anti-inflammatory drug (NSAID) use has been linked with pancreatic cancer risk; however, findings from epidemiological studies are inconsistent. METHODS: A nested case-control study was conducted within the UK General Practice Research Database. Cases (n=1141) had a diagnosis of primary cancer of the exocrine pancreas between January 1995 and June 2006. Controls (n=7954) were matched with each case on general practice site, sex and year of birth. Conditional logistic regression analyses were used to generate odds ratios (OR) and 95% confidence intervals (CI) associated with NSAID use compared with non-use. RESULTS: Any use of NSAID in the 5 years before the index date or since entry into the database (excluding the year before diagnosis) was not associated with risk of pancreatic cancer; OR 0.96 (95% CI, 0.84-1.10) and 1.03 (95% CI 0.89-1.19), respectively. Exposure to NSAIDs for > 773 days, in the 5 years pre-diagnosis, was associated with a reduced risk of pancreatic cancer OR 0.78 (95%CI 0.62-0.97). There was evidence of reduced pancreatic cancer risk with long-term use (5 years or more) of lower doses of NSAIDs OR 0.70 (95% CI 0.49-0.99). CONCLUSION: Long-term exposure to NSAIDs may be associated with a reduction in risk of pancreatic cancer. |
|---|
| ジャーナル名 | British journal of cancer |
|---|
| Pubmed追加日 | 2010/4/8 |
|---|
| 投稿者 | Bradley, M C; Hughes, C M; Cantwell, M M; Napolitano, G; Murray, L J |
|---|
| 組織名 | Cancer Epidemiology and Prevention Research Group, Centre for Public Health,;Queen's University, Mulhouse Building, Royal Victoria Hospital, Belfast BT12 6BJ,;Northern Ireland, UK. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/20372155/ |
|---|
